Objectives To investigate the efficacy and safety of subcutaneous clonidine for refractory symptoms in the palliative setting. Methods A retrospective chart review of the use of subcutaneous clonidine ...

Breast cancer for many women is a horrific incident and makes the person encounter psychological and social challenges, including anxiety and particularly death anxiety. Among humankind, the most ...

Primary Palliative Care Research Group, University of Edinburgh, Edinburgh, UK Correspondence to Iain Harris, Primary Palliative Care Research Group, University of Edinburgh, Medical School, Teviot ...

Background Falls guidelines were updated for the hospice in 2022 with risk assessment currently based on the Morse Falls Scale and NICE quality standards on falls. New Assessment frameworks were also ...

Correspondence to Dr Jason Boland, Senior lecturer and honorary consultant in palliative medicine, Hull York Medical School, Hertford Building, University of Hull ...

Objectives Patient-relevant measures of functional status are required in chronic obstructive pulmonary disease (COPD) and lung cancer in clinical practice and research. We explored the relationship ...

Background End-stage kidney disease (ESKD) significantly impacts global public health, driven by an ageing population and increased chronic diseases. Over half of patients with ESKD are now over 65 ...

Using a systematic approach covering virtue ethics, deontology and a brief overview of other ethical and moral considerations, we present a balanced consideration of the assisted dying bill currently ...

In January 2025, President Trump immediately paused US foreign development assistance, upending healthcare in many low- and ...

Background The integration of palliative care for individuals with psychiatric disorders is critically important yet remains under-researched, highlighting substantial gaps in healthcare systems and ...

Crisis pack prescribing in terminal haemorrhage: a national survey of specialist palliative medicine physicians (4 March, 2025) ...